Drilldown: Medicines
Appearance
Medicines > onset
:
15–30 min
or
PO 1–2 h; IM 30–60 min; IV 5–20 min
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
:
15–30 min
or
PO 1–2 h; IM 30–60 min; IV 5–20 min
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
Antiemetic (1) ·
Caffeine plant (1) ·
Cathinone source (1) ·
Excitantia (2) ·
Plant Medicine (2) ·
Typical antipsychotic (1) ·
[[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]] (2) ·
[[:Category:DPP-4_inhibitors|DPP-4 inhibitor]] (2) ·
[[:Category:Incretin_modulators|Incretin pathway modulator]] (2)
None (1) ·
Caffeine + theophylline + L-theanine. L-theanine (an amino acid unique to tea) modulates glutamate and produces an 'alpha-wave' calming overlay on caffeine's stimulation, hence tea's reputation as a 'cleaner' stimulant than coffee. (1) ·
High-affinity D2 receptor antagonist (1) ·
Primary alkaloid is (S)-(-)-cathinone, a phenylpropanolamine close kin to amphetamine. Releases dopamine and norepinephrine. Also contains cathine (=norpseudoephedrine) and norephedrine. (1) ·
'"`UNIQ--vote-00000762-QINU`"' Largely renally cleared, hence the eGFR-tiered dosing. Rare but well-documented signals: acute pancreatitis (uncertain causal contribution), severe joint pain, and bullous pemphigoid (class effect, especially in older Asian patients)'"`UNIQ--ref-00000763-QINU`"'. (1)
Schizophrenia, acute psychosis, agitation, delirium, Tourette syndrome, severe nausea (1) ·
'"`UNIQ--vote-00000008-QINU`"', '"`UNIQ--vote-00000009-QINU`"' (1) ·
'"`UNIQ--vote-00000747-QINU`"', '"`UNIQ--vote-00000748-QINU`"' (1) ·
'"`UNIQ--vote-00000764-QINU`"' (1) ·
'"`UNIQ--vote-0000117B-QINU`"' (1)
Showing below up to 5 results in range #1 to #5.

